Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Targeting LGR4 may help treat cancer by reducing cancer stem cell traits and drug resistance.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

MM-CEP/NLCs could effectively treat lung inflammation.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Blocking mTORC1 reduces skin tumor growth in mice.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Blocking androgen receptors helps immune cells better fight certain bacteria.

Targeting CD169+ skin macrophages may help treat psoriasis.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

XEDAR triggers a specific signaling pathway in cells.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Deucravacitinib may effectively treat discoid lupus erythematosus.